Immuneering
Amy Axel is an experienced professional in scientific operations and research, currently serving as the Director of Scientific Operations at Immuneering Corporation since January 2021, after holding the role of Associate Director of Operations. Prior experience includes over a decade at Johnson & Johnson, where Amy held positions including Principal Operations Specialist and Senior Scientist, focusing on oncology biomarkers, translational research, and assay development. Earlier roles include Senior Associate Scientist at Nationwide Children's Hospital, where contributions were made to tumor modeling and grant applications, and research positions at The Ohio State University and Cincinnati Children's Hospital Medical Center. Amy holds a Bachelor of Science degree in Molecular Genetics from The Ohio State University.
This person is not in any offices
Immuneering
1 followers
Immuneering leverages more than a decade of leadership in bioinformatics to develop new medicines unlikely to be found by traditional drug discovery methods. Its current pipeline of drug candidates is focused on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis.